Life Science & Diagnostics: Revvity • Prahlad Singh
Description
Signal vs. Noise: Revvity's Data Strategy for the Future of Life Sciences
The life sciences and diagnostics industry is evolving faster than ever. We sit down with Prahlad Singh, CEO of Revvity, to discuss this dramatic shift. Prahlad explains the vision behind Revvity's major rebranding (formerly PerkinElmer), moving from a tools provider to a high-value, end-to-end solutions partner. The focus? Agility, innovation, and data. We explore how their Signals Platform is the new "crown jewel" that addresses the immense complexity in fields like genomics, multi-omics, and precision medicine. Learn why advanced data analytics is no longer optional—it's essential for navigating the future of science.Tune in to understand how Revvity is anticipating client needs and driving the next generation of scientific breakthroughs.
United States
